1. Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide. Issue 10 (October 2020) Authors: Roade, Luisa; Loglio, Alessandro; Borghi, Marta; Riveiro-Barciela, Mar; Soffredini, Roberta; Facchetti, Floriana; di Paolo, Dhanai; Tabernero, David; Lunghi, Giovanna; Esteban, Rafael; Buti, Maria; Lampertico, Pietro Journal: Digestive and liver disease Issue: Volume 52:Issue 10(2020) Page Start: 1164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Circulating cell‐free DNA species affect the risk of hepatocellular carcinoma in treated chronic hepatitis B patients. Issue 3 (16th December 2020) Authors: Papatheodoridi, Alkistis; Chatzigeorgiou, Antonios; Chrysavgis, Lampros; Lembessis, Panagiotis; Loglio, Alessandro; Facchetti, Floriana; Cholongitas, Evangelos; Koutsilieris, Michael; Lampertico, Pietro; Papatheodoridis, George Journal: Journal of viral hepatitis Issue: Volume 28:Issue 3(2021) Page Start: 464 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dual proteotoxic stress accelerates liver injury via activation of p62‐Nrf2. Issue 1 (18th March 2021) Authors: Kuscuoglu, Deniz; Bewersdorf, Lisa; Wenzel, Kathrin; Gross, Annika; Kobazi Ensari, Gökce; Luo, Yizhao; Kilic, Konrad; Hittatiya, Kanishka; Golob‐Schwarzl, Nicole; Leube, Rudolf E; Preisinger, Christian; George, Jacob; Metwally, Mayada; Eslam, Mohammed; Lampertico, Pietro; Petta, Salvatore; Mangia... Journal: Journal of pathology Issue: Volume 254:Issue 1(2021) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir. (7th January 2019) Authors: Viganò, Mauro; Loglio, Alessandro; Labanca, Sara; Zaltron, Serena; Castelli, Francesco; Andreone, Pietro; Messina, Vincenzo; Ganga, Roberto; Coppola, Nicola; Marrone, Aldo; Russello, Maurizio; Marzano, Alfredo; Tucci, Alessandra; Taliani, Gloria; Fasano, Massimo; Fagiuoli, Stefano; Villa, Erica; ... Journal: Liver international Issue: Volume 39:Number 3(2019) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hepatitis B virus long‐term impact of antiviral therapy nucleot(s)ide analogues (NUCs). (January 2017) Authors: Grossi, Glenda; Viganò, Mauro; Loglio, Alessandro; Lampertico, Pietro Journal: Liver international Issue: Volume 37(2017)Supplement 1 Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Hepatitis D – how is the fight against this foe going?. Issue 3 (4th March 2019) Authors: Loglio, Alessandro; Segato, Simone; Lampertico, Pietro Journal: Expert review of clinical pharmacology Issue: Volume 12:Issue 3(2019) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals?. Issue 1 (2nd January 2020) Authors: Loglio, Alessandro; Lampertico, Pietro Journal: Hepatology communications Issue: Volume 4:Issue 1(2020) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. IFNL4 rs368234815 and rs117648444 variants predict off‐treatment HBsAg seroclearance in IFN‐treated HBeAg‐negative chronic hepatitis B patients. (10th August 2017) Authors: Galmozzi, Enrico; Facchetti, Floriana; Grossi, Glenda; Loglio, Alessandro; Viganò, Mauro; Lunghi, Giovanna; Colombo, Massimo; Lampertico, Pietro Journal: Liver international Issue: Volume 38:Number 3(2018) Page Start: 417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Incremental value of HBcrAg to classify 1582 HBeAg‐negative individuals in chronic infection without liver disease or hepatitis. Issue 6 (19th January 2021) Authors: Brunetto, Maurizia R.; Carey, Ivana; Maasoumy, Benjamin; Marcos‐Fosch, Cristina; Boonstra, André; Caviglia, Gian Paolo; Loglio, Alessandro; Cavallone, Daniela; Scholtes, Caroline; Ricco, Gabriele; Smedile, Antonina; Riveiro‐Barciela, Mar; van Bömmel, Florian; van der Eijk, Annemiek; Zoulim, Fabie... Journal: Alimentary pharmacology & therapeutics Issue: Volume 53:Issue 6(2021) Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma. Issue 3 (March 2019) Authors: Loglio, Alessandro; Viganò, Mauro; Grossi, Glenda; Labanca, Sara; Goldaniga, Maria; Pompa, Alessandra; Farina, Lucia; Rumi, Mariagrazia; Corradini, Paolo; Facchetti, Floriana; Lunghi, Giovanna; Baldini, Luca; Lampertico, Pietro Journal: Digestive and liver disease Issue: Volume 51:Issue 3(2019) Page Start: 419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗